Skip to main content
. 2011 Mar 28;26(4):551–560. doi: 10.3346/jkms.2011.26.4.551

Fig. 1.

Fig. 1

Progression-free survival curves for the patients with homogeneously versus heterogeneously enhanced primary central nervous system lymphoma.